MedKoo Cat#: 574368 | Name: JW-67
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

JW-67 is a Wnt pathway inhibitor that targets the β-catenin destruction complex (GSK-3β/AXIN/APC) to induce β-catenin degradation. JW-67 is selective for the canonical Wnt pathway over the Sonic hedgehog (Shh) and NF-κB pathways. It blocks G1/S cell cycle progression in colorectal cancer (CRC) cell lines.

Chemical Structure

JW-67
JW-67
CAS#442644-28-2

Theoretical Analysis

MedKoo Cat#: 574368

Name: JW-67

CAS#: 442644-28-2

Chemical Formula: C21H18N2O6

Exact Mass: 394.1165

Molecular Weight: 394.38

Elemental Analysis: C, 63.96; H, 4.60; N, 7.10; O, 24.34

Price and Availability

Size Price Availability Quantity
10mg USD 385.00 2 Weeks
25mg USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
JW-67, JW67, JW 67
IUPAC/Chemical Name
trispiro[indoline-3,2'-[1,3]dioxane-5',5''-[1,3]dioxane-2'',3'''-indoline]-2,2'''-dione
InChi Key
BTXRSHKJNDFHGA-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H18N2O6/c24-17-20(13-5-1-3-7-15(13)22-17)26-9-19(10-27-20)11-28-21(29-12-19)14-6-2-4-8-16(14)23-18(21)25/h1-8H,9-12H2,(H,22,24)(H,23,25)
SMILES Code
O=C1NC6=C(C=CC=C6)C21OCC3(COC(C(NC5=C4C=CC=C5)=O)4OC3)CO2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
JW67 inhibits the canonical Wnt signaling with an IC50 of 1.17μM.
In vitro activity:
In human colorectal cancer (CRC) cells, the new compounds JW67 and JW74 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1. Reference: Cancer Res. 2011 Jan 1;71(1):197-205. https://pubmed.ncbi.nlm.nih.gov/21199802/
In vivo activity:
High fat diet-induced obesity (DIO) mouse model and 3T3-L1 cell model were used to assess the anti-obesity effects of T2-3. Indeed, upregulation of β-catenin activity suppressed adipogenesis, while β-catenin inhibitor JW67 reversed the anti-adipogenic effect of T2-3. Reference: Phytomedicine. 2022 Nov;106:154396. https://pubmed.ncbi.nlm.nih.gov/36057145/
Solvent mg/mL mM
Solubility
DMSO 44.7 113.39
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 394.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Waaler J, Machon O, von Kries JP, Wilson SR, Lundenes E, Wedlich D, Gradl D, Paulsen JE, Machonova O, Dembinski JL, Dinh H, Krauss S. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 2011 Jan 1;71(1):197-205. doi: 10.1158/0008-5472.CAN-10-1282. PMID: 21199802. 2. Chen B, Shi Z, Wang Y, Chen M, Yang C, Cui H, Su T, Kwan HY. Discovery of a novel anti-obesity meroterpenoid agent targeted subcutaneous adipose tissue. Phytomedicine. 2022 Nov;106:154396. doi: 10.1016/j.phymed.2022.154396. Epub 2022 Aug 21. PMID: 36057145.
In vitro protocol:
1. Waaler J, Machon O, von Kries JP, Wilson SR, Lundenes E, Wedlich D, Gradl D, Paulsen JE, Machonova O, Dembinski JL, Dinh H, Krauss S. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 2011 Jan 1;71(1):197-205. doi: 10.1158/0008-5472.CAN-10-1282. PMID: 21199802.
In vivo protocol:
1. Chen B, Shi Z, Wang Y, Chen M, Yang C, Cui H, Su T, Kwan HY. Discovery of a novel anti-obesity meroterpenoid agent targeted subcutaneous adipose tissue. Phytomedicine. 2022 Nov;106:154396. doi: 10.1016/j.phymed.2022.154396. Epub 2022 Aug 21. PMID: 36057145.
1. Shultz et al (2012) [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding. J.Med.Chem. 55 1127 PMID: 22260203 2. Waaler et al (2011) Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 71 197 PMID: 21199802